Fatty liver index

There are 143 papers on fatty liver index in aging research: 20 trials and 119 observational studies in people, 4 reviews. The newest story, Nov 9, 2026: “Muscle-related genetic score linked to lower liver disease odds”.

Biomarker

143 papers study it20 more mention it69 findings

23 new papers in 30 daysSee all 163 papers on fatty liver index

“FLI and LAP presented the highest AUC values for identifying obesity in both sexes”
Diagnostic accuracy of non-invasive fatty liver indexes and their association with ECORE-BF scale in a cohort of 386,924 Spanish workersGastroenterologia y hepatologia2026doi:10.1016/j.gastrohep.2026.502656
  • Human trial20
  • Humans119

Interventions

18

Glucoerb + epavin

downin humans1−17%

1 study
  1. Glucoerb + epavin decreases fatty liver index in humans (-17%).

    “Group 3 showed a significant reduction in HOMA-IR (−32%, p = 0.006), TC (−4%, p < 0.001), LDL-C (−9%, p = 0.049), and FLI (−17%, p < 0.001).”

    Human trial3-month follow-upn = 50

    Effects of Glucoerb® and Epavin® on Cardiometabolic Profile in Adults with Overweight or Obesity: A Three-Month Real-World Study

    Journal of clinical medicine

  2. Glucoerb + epavin is linked with lower fatty liver index in humans (-17%).

    “Fatty Liver Index decreased across all groups (Glucoerb® -14%, Epavin® -19%, combination -17%).”

    HumansOverweight or obesity; alongside nutritional counselling and physical activity recommendations3 monthsn = 50

    Effects of Glucoerb® and Epavin® on Cardiometabolic Profile in Adults with Overweight or Obesity: A Three-Month Real-World Study

    Journal of clinical medicine

More on Glucoerb + epavin

Caloric restriction

downin humans1

1 study
  1. Caloric restriction decreases fatty liver index in humans.

    “At completion of 6 months, both groups experienced a statistically significant reduction in FLI, with no significant between-group differences for the change after 3 months (interaction, p=0.50) or 6 months (interaction, p=0.56).”

    Human trial12 monthsn = 17

    Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial

    BMJ open diabetes research & care

  2. Caloric restriction decreases fatty liver index in humans (overweight and obese adults with type 2 diabetes) (-9 (95% CI -15 to -4)).

    “PRT+WL, -12 (-20 to -4); WL, -9 (-15 to -4)), with no significant between-group difference.”

    Human trialoverweight and obese adults with type 2 diabetes6 monthsn = 17

    Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial

    BMJ open diabetes research & care

More on Caloric restriction

Progressive resistance training + caloric restriction

downin humans1

1 study
  1. Progressive resistance training + caloric restriction decreases fatty liver index in humans.

    “At completion of 6 months, both groups experienced a statistically significant reduction in FLI, with no significant between-group differences for the change after 3 months (interaction, p=0.50) or 6 months (interaction, p=0.56).”

    Human trial12 monthsn = 19

    Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial

    BMJ open diabetes research & care

  2. Progressive resistance training + caloric restriction decreases fatty liver index in humans (overweight and obese adults with type 2 diabetes) (-12 (95% CI -20 to -4)).

    “Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, -12 (-20 to -4); WL, -9 (-15 to -4))”

    Human trialoverweight and obese adults with type 2 diabetes6 monthsn = 19

    Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial

    BMJ open diabetes research & care

More on Progressive resistance training + caloric restriction

Micronutrient supplementation

no changein humans1

1 study
  1. Micronutrient supplementation showed no clear effect on fatty liver index in humans (MASLD; single-arm, within-participant comparison) (−4.3%; p = 0.256).

    “The primary efficacy target was not achieved: mean FLI decreased from 59.18 to 56.63 (−4.3%; p = 0.256).”

    Human trialMASLD; single-arm, within-participant comparisontwo micronutrient formulationsfour monthsn = 15

    Targeted Micronutritional Support in Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Prospective, Single-Arm Pilot Study of Hepatic Steatosis and Cardiometabolic Outcomes

    Nutrients

More on Micronutrient supplementation

Micronutrients

no changein humans1−4.3% relative reduction

1 study
  1. Micronutrients showed no clear effect on fatty liver index in MASLD patients (-4.3% relative reduction).

    “Mean FLI decreased by 2.55 points (59.18 ± 26.67 to 56.63 ± 27.48), corresponding to a 4.3% relative reduction (p = 0.256).”

    Human trialin MASLD patientstwo standardized micronutrient formulations4 monthsn = 15

    Targeted Micronutritional Support in Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Prospective, Single-Arm Pilot Study of Hepatic Steatosis and Cardiometabolic Outcomes

    Preprints.orgPreprint

More on Micronutrients

Air pollution

no changein humans1

1 study
  1. Air pollution was not clearly linked with fatty liver index in humans After concurrent adjustment for Townsend deprivation in the UK contextual model (β -0.068, 95% CI -0.137 to 0.001).

    “The positive age-adjusted pollution associations were attenuated after Townsend adjustment (FLI β = -0.068, 95% CI -0.137 to 0.001;”

    HumansAfter concurrent adjustment for Townsend deprivation in the UK contextual modelresidential 2010 PM2.5-NO2 scorefemalesn = 231,525

    Socioeconomic disadvantage, air pollution, and metabolic health among women: analyses of UK Biobank and US data

    Frontiers in endocrinology

More on Air pollution

Spermidine

downin humans1

1 study
  1. Spermidine decreases fatty liver index in humans (cluster 3, highest baseline and increased 1-year spermidine intake) (-8.97 [-9.96 to -7.97]).

    “was associated with mean reductions in fatty liver index (- 8.97 [- 9.96 to - 7.97], p-int < 0.001)”

    Human trialcluster 3, highest baseline and increased 1-year spermidine intakeliver1 year

    Rising spermidine intake linked to better liver scores

    European journal of nutrition

More on Spermidine

Renal denervation

downin humans1

1 study
  1. Renal denervation decreases fatty liver index in humans (uncontrolled hypertension and cardiometabolic comorbidities) (2.0±2.7 vs -6.2±1.3 at 12 months, P=0.018).

    “as well as FLI at 3 months (2.6±2.2 versus -3.8±1.2; P=0.021), 6 months (4.1±2.4 versus -5.7±1.2; P=0.002), and 12 months (2.0±2.7 versus -6.2±1.3; P=0.018).”

    Human trialuncontrolled hypertension and cardiometabolic comorbidities12 months

    Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome

    Hypertension (Dallas, Tex. : 1979)

More on Renal denervation

Tofogliflozin

upin humans1

1 study
  1. Tofogliflozin improves fatty liver index in humans (treatment-naïve type 2 diabetes).

    “The fatty liver index improved significantly more in the tofogliflozin group.”

    Human trialtreatment-naïve type 2 diabetes20 mg/day vs 500 mg/day metformin4 weeks

    Effects of short-term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP-ELM study

    Journal of diabetes investigation

More on Tofogliflozin

EMP16

downin humans1

1 study
  1. EMP16 decreases fatty liver index in humans (compared with conventional orlistat) (greater improvement than Conv-O).

    “EMP16 demonstrating greater improvement in fatty liver index and quality of life compared to Conv-O (p < 0.01)”

    Human trialcompared with conventional orlistatliver6 months

    The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial

    Obesity (Silver Spring, Md.)

More on EMP16

Orlistat + acarbose

downin humans1

1 study
  1. Orlistat + acarbose decreases fatty liver index in humans.

    “Participants on EMP16‐120/40 had a larger decrease in FLI compared to participants on MR‐O (p = 0.047) and Conv‐O (p < 0.001).”

    Human trial26‐week treatment periodn = 240

    The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial

    Obesity (Silver Spring, Md.)

More on Orlistat + acarbose

Bovine collagen

downin humans1

1 study
  1. Bovine collagen decreases fatty liver index in humans.

    “It is important to note that systolic blood pressure and FLI were significantly lower in the Collagen group with respect to the Control group at V2 and V3”

    Human trial12 weeksn = 64

    Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial

    Nutrients

More on Bovine collagen

Exercise

downin humans1

1 study
  1. Exercise decreases fatty liver index in patients with metabolic syndrome and liver steatosis (p < 0.001).

    “This study demonstrated that all three training programs significantly improve FLI and that this effect was lasting among the follow-up (p < 0.001).”

    Human trialin patients with metabolic syndrome and liver steatosis3 weeksn = 85

    Effect of different modalities of exercise on Fatty Liver Index in patients with metabolic syndrome: The RESOLVE randomized trial

    Clinics and research in hepatology and gastroenterology

More on Exercise

Progressive resistance training

no changein humans1

1 study
  1. Progressive resistance training showed no clear effect on fatty liver index in humans (combined with weight loss).

    “At completion of 6 months, both groups experienced a statistically significant reduction in FLI, with no significant between-group differences for the change after 3 months (interaction, p=0.50) or 6 months (interaction, p=0.56).”

    Human trialcombined with weight loss12 monthsn = 36

    Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial

    BMJ open diabetes research & care

More on Progressive resistance training

Testosterone undecanoate

downin humans1

1 study
  1. Testosterone undecanoate decreases fatty liver index in humans (hypogonadal men) (from a mean [SD] of 83.70 [12.15] to 67.12 [19.21]).

    “The T-group showed a decrease in the FLI (from a mean [SD] of 83.70 [12.15] to 67.12 [19.21])”

    Human trialhypogonadal mentestosterone undecanoate1000 mg every 12 weeks8 yearsmalesn = 312

    Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study

    Arab journal of urology

More on Testosterone undecanoate

All 18

Effects

4

PhenoAge

upin humans1

1 study
  1. Fatty liver index is linked with higher PhenoAge in humans (β 3.33, 95% CI 3.07–3.58).

    “females exhibited stronger associations with PhenoAge (βfemale = 3.33, 95% confidence interval [CI]: 3.07-3.58; βmale = 2.54, 95% CI: 2.20-2.89)”

    Humansfemales

    Sex differences in the association between fatty liver index and biological aging: A mediation analysis of insulin resistance in a cross-sectional study

    Medicine

More on PhenoAge

Alzheimer's disease

no changein humans1

1 study
  1. Fatty liver index was not clearly linked with Alzheimer's disease in humans.

    “No significant associations were found with Alzheimer's disease, influenza and pneumonia, chronic lower respiratory diseases, or renal disorders.”

    Humansmedian 26.25 yearsn = 11,297

    Fatty liver index as an independent predictor of all-cause and disease-specific mortality

    European journal of gastroenterology & hepatology

More on Alzheimer's disease

Detection of prevalent cardiometabolic multimorbidity

upin humans1

1 study
  1. Fatty liver index is linked with better detection of prevalent cardiometabolic multimorbidity in humans (Added to conventional cardiometabolic risk factors) (AUC 0.920 vs. 0.983, P < 0.001).

    “an incremental value of FLI for detecting prevalent CMM when adding it to conventional cardiometabolic risk factors (Area under the curve: 0.920 vs. 0.983, P < 0.001).”

    HumansAdded to conventional cardiometabolic risk factorsn = 26,269

    Association between fatty liver index and cardiometabolic multimorbidity: evidence from the cross-sectional national health and nutrition examination survey

    Frontiers in cardiovascular medicine

Muscle density

downin humans1

1 study
  1. Fatty liver index is linked with lower muscle density in humans (-2.1%, p < 0.001).

    “After adjusting for age and lifestyle, mean radial muscle density in Q4 was 2.1% lower than Q1 (p < 0.001)”

    Humansmalesn = 403

    Fatty Liver Index and Skeletal Muscle Density

    Calcified tissue international

More on Muscle density

Upstream

1

Postmenopausal status

upin humans1

1 study
  1. Postmenopausal status is linked with higher fatty liver index in humans.

    “Females exhibited higher mean FLI values than males, with postmenopausal women demonstrating significantly elevated FLI scores compared to pre menopausal women.”

    Humans

    Age and Gender Related Differences in Non Alcoholic Fatty Liver Disease Risk: Role of Cardio metabolic Factors, Obesity and Menopausal Status in an Indian Tertiary Care Population

    Scientific Hub of Applied Research in Emerging Medical science & technology

Associations

42

Major adverse cardiovascular events

mixedin humans1upin humans1

2 studies
  1. Fatty liver index is associated with major adverse cardiovascular events in humans (new-onset atrial fibrillation) (nonlinear, triphasic relationship with two thresholds).

    “A restricted cubic spline analysis revealed a non-linear, triphasic dose-response relationship between the FLI and MACE, with two distinct thresholds.”

    Humansnew-onset atrial fibrillation

    Fatty liver is linked to heart risks with an irregular heartbeat

    ESC Congress 2026 abstract

  2. Fatty liver index is associated with major adverse cardiovascular events in humans (CKM stages 0–3).

    “elevated FLI, CysC, and hsCRP were independently associated with MACE across all CKM stages.”

    HumansCKM stages 0–3Median follow-up of 15.2 yearsn = 382,797

    Aggregate risk score based on markers of hepatic steatosis, systemic inflammation, and renal stress to predict MACE across the CKM spectrum

    ESC Congress 2026 abstract

Tryptophan-kynurenine pathway metabolites

upin humans1

1 study
  1. Tryptophan-kynurenine pathway metabolites are associated with fatty liver index in humans (fully adjusted logistic regression model).

    “In the fully adjusted logistic regression model, higher levels of these metabolites remained independently associated with an increased risk of elevated FLI.”

    Humansfully adjusted logistic regression modelplasman = 396

    Association of B-Vitamin–Related Tryptophan–Kynurenine Pathway Metabolites with Fatty Liver Index in Older Adults: Findings from the Bushehr Elderly Health Study

    Iranian Journal of Diabetes and Metabolism

More on Tryptophan-kynurenine pathway metabolites

Gestational diabetes mellitus

upin humans1RR 1.8

1 study
  1. Fatty liver index is associated with gestational diabetes mellitus in humans (First-trimester pregnancy; elevated Fatty Liver Index >32 versus normal Fatty Liver Index) (Adjusted RR 1.80, 95% CI 1.29–2.52; incidence 40.9% versus 20.3%).

    “Elevated FLI remained significantly associated with GDM after adjustment (aRR 1.80, 95% CI 1.29–2.52).”

    HumansFirst-trimester pregnancy; elevated Fatty Liver Index >32 versus normal Fatty Liver Indexfemalesn = 354

    First-trimester Fatty Liver Index and Subsequent Incidence of Gestational Diabetes Mellitus: A Community-based Prospective Cohort Study in South India

    Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine

More on Gestational diabetes mellitus

SLC16A11 RS13342232 G/G genotype

upin humans1

1 study
  1. SLC16A11 rs13342232 G/G genotype is associated with fatty liver index in humans (VAT × G/G interaction in Mexican adults with and without type 2 diabetes) (Interaction β = 3.19, 95% CI 0.23–6.15; p = 0.035).

    “A significant VAT × G/G interaction on FLI was observed in the full sample (β = 3.19, 95% CI 0.23–6.15; p = 0.035).”

    HumansVAT × G/G interaction in Mexican adults with and without type 2 diabetesn = 607

    Genotype and Visceral Adiposity Interactions on Hepatic Steatosis in Mexican Adults

    Journal of the Endocrine Society

Breast cancer

upin humans1RR 1.09

1 study
  1. Fatty liver index is associated with breast cancer in humans (Intermediate fatty liver index versus low fatty liver index) (Adjusted RR 1.09 (95% CI 1.02–1.16); HR 1.08 (95% CI 1.01–1.15)).

    “Compared with women in the low FLI group, those in the intermediate FLI group had an adjusted RR of 1.09 (95% CI, 1.02–1.16)”

    HumansIntermediate fatty liver index versus low fatty liver indexfemales

    Fatty liver index and breast cancer risk: age-stratified findings from a prospective electronic health record–based cohort

    Frontiers in oncology

More on Breast cancer

Hepatocellular carcinoma risk

mixedin humans1

1 study
  1. Fatty liver index predicts hepatocellular carcinoma risk in humans (Individuals without viral hepatitis).

    “SHAP analysis identified fatty liver index (FLI) and triglycerides (TG) as the most influential predictors.”

    HumansIndividuals without viral hepatitis

    Artificial intelligence-based prediction of hepatocellular carcinoma in individuals without HBV or HCV infection in the MASLD era

    Scientific reports

More on Hepatocellular carcinoma risk

Estimated glomerular filtration rate slope

downin humans1

1 study
  1. Fatty liver index is associated with estimated glomerular filtration rate slope in humans (Higher fatty liver index categories).

    “Higher FLI categories were associated with progressively steeper eGFR decline.”

    HumansHigher fatty liver index categorieskidney16 years

    Metabolic dysfunction-associated fatty liver disease and long-term kidney function decline: a 16-year population-based cohort study

    Scientific reports

More on Estimated glomerular filtration rate slope

Socioeconomic disadvantage

upin humans1

1 study
  1. Socioeconomic disadvantage is associated with fatty liver index in humans (UK contextual model jointly adjusted for air pollution, age, and collapsed ethnicity) (β 1.114, 95% CI 1.069 to 1.159).

    “Townsend deprivation was associated with higher FLI [β = 1.114, 95% confidence interval (CI) 1.069 to 1.159]”

    HumansUK contextual model jointly adjusted for air pollution, age, and collapsed ethnicityTownsend deprivationfemalesn = 231,525

    Socioeconomic disadvantage, air pollution, and metabolic health among women: analyses of UK Biobank and US data

    Frontiers in endocrinology

More on Socioeconomic disadvantage

Lipoprotein-related insulin resistance

upin humans1

1 study
  1. Fatty liver index is associated with lipoprotein-related insulin resistance in humans (fully adjusted models; higher fatty liver index).

    “and greater lipoprotein-related insulin resistance (all P <.001)”

    Humansfully adjusted models; higher fatty liver indexn = 1,713

    Fatty liver index and atherogenic risk determined by lipoprotein particle subclasses: A cross-sectional study of middle- to older-aged adults

    Journal of clinical lipidology

More on Lipoprotein-related insulin resistance

Lipoprotein particle subclass concentrations

mixedin humans1

1 study
  1. Fatty liver index is associated with lipoprotein particle subclass concentrations in humans (fully adjusted models; higher fatty liver index).

    “more large and medium VLDL, small LDL, and less large HDL particle concentrations”

    Humansfully adjusted models; higher fatty liver indexn = 1,713

    Fatty liver index and atherogenic risk determined by lipoprotein particle subclasses: A cross-sectional study of middle- to older-aged adults

    Journal of clinical lipidology

More on Lipoprotein particle subclass concentrations

All 42

Latest

Dec 2025: 3Jan 2026: 10Feb 2026: 10Mar 2026: 10Apr 2026: 0May 2026: 2Jun 2026: 2Jul 2026: 6Aug 2026: 8Sep 2026: 10Oct 2026: 14Nov 2026: 984 papers in 12 months
Biomedicines

Muscle-related genetic score linked to lower liver disease odds

Higher genetic scores were linked to lower odds of nonalcoholic fatty liver disease, with an odds ratio of 0.97 compared with lower scores.Higher genetic scores were linked to lower odds of nonalcoholic fatty liver disease, with an odds ratio of 0.97 compared with lower scores.

Genetic association · 389,804 peopleLiver disease
Cardiovascular Diabetology

Fatty liver score linked to diabetes and cardiovascular events

High versus lower fatty liver scores had hazard ratios—relative measures of risk over time—of 1.67 for diabetes and 1.21 for cardiovascular events.High versus lower fatty liver scores had hazard ratios—relative measures of risk over time—of 1.67 for diabetes and 1.21 for cardiovascular events.

Cohort · 142,518 peopleIncident diabetes

See all 163 papers on fatty liver index